Key facts
- Checkerspot’s last known valuation is $347.0M (Sep 2022).
- It has raised $157.0M across 5 recorded rounds; the latest was Early Stage VC ($7.6M) in Nov 2025.
- Notable investors include Plug and Play Tech Center, Viking Global Investors, United States Department of Agriculture, Builders VC, Refactor Capital — 19 tracked in total.
- Checkerspot has filed 4 Form Ds with the SEC since 2018, most recently Dec 2025 ($7.6M sold to 6 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 19 names
- ·Watchlist + deal alerts for Checkerspot
Funding rounds
5 roundsAbout Checkerspot
Developer of a biotechnology platform intended to engineer fats and oils through precision fermentation to create functional lipids that support nutritional needs across all life stages. The company's platform offers biology-driven lipid development and a molecule-licensing model, enabling food, nutrition, and ingredient partners to access sustainably produced functional lipids at scalable production levels and viable cost.
- Industry
- Biotechnology
- Sector
- Healthcare
- HQ
- Alameda, CA, United States
- Founded
- 2016
- Employees
- 34
- Website
- checkerspot.com/
- Ownership
- Privately Held (backing)
Checkerspot doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Checkerspot shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Checkerspot in its N-PORT filings yet. We sweep new filings monthly.